Recombinant APOA2 anticorps
Aperçu rapide pour Recombinant APOA2 anticorps (ABIN7127342)
Antigène
Voir toutes APOA2 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human APOA2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
Autre désignation
- APOA2
-
Sujet
-
Background: May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism.
Aliases: Apolipoprotein A-II, Apo-AII, ApoA-II, Apolipoprotein A2, Proapolipoprotein A-II, ProapoA-II, Truncated apolipoprotein A-II, Apolipoprotein A-II(1-76), APOA2
-
UniProt
- P02652
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Antigène
-